IL89222A - Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins - Google Patents

Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins

Info

Publication number
IL89222A
IL89222A IL8922289A IL8922289A IL89222A IL 89222 A IL89222 A IL 89222A IL 8922289 A IL8922289 A IL 8922289A IL 8922289 A IL8922289 A IL 8922289A IL 89222 A IL89222 A IL 89222A
Authority
IL
Israel
Prior art keywords
group
protein
groups
radionuclide
proteinaceous material
Prior art date
Application number
IL8922289A
Other languages
English (en)
Other versions
IL89222A0 (en
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of IL89222A0 publication Critical patent/IL89222A0/xx
Publication of IL89222A publication Critical patent/IL89222A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL8922289A 1988-02-09 1989-02-08 Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins IL89222A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL8800302 1988-02-09
NL8801728 1988-07-08
NL8802408 1988-09-30

Publications (2)

Publication Number Publication Date
IL89222A0 IL89222A0 (en) 1989-09-10
IL89222A true IL89222A (en) 1995-03-30

Family

ID=27352196

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8922289A IL89222A (en) 1988-02-09 1989-02-08 Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins

Country Status (7)

Country Link
EP (1) EP0401302B1 (fr)
AT (1) ATE124269T1 (fr)
AU (2) AU635204B2 (fr)
DE (1) DE68923274T2 (fr)
FI (1) FI903917A7 (fr)
IL (1) IL89222A (fr)
WO (1) WO1989007456A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990006774A1 (fr) * 1988-12-22 1990-06-28 Xoma Corporation Procedes et agents de liaison bloques
FR2650749B1 (fr) * 1989-08-08 1994-09-02 Univ Rouen Methode de diagnostic et/ou de traitement, notamment du cancer
CA2065362A1 (fr) * 1989-08-24 1991-02-25 Fook-Thean Lee Anticorps marques radioactivement pour imagerie
JPH05504763A (ja) * 1989-11-30 1993-07-22 マリンクロッド・メディカル・インコーポレイテッド 金属放射性核種でラベル付けされたタンパク質の調製方法
EP0485664A1 (fr) * 1990-11-13 1992-05-20 Mallinckrodt Diagnostica (Holland) B.V. Procédé de préparation d'agent diagnostique pour la détection des inflammations
FI920459A7 (fi) * 1991-02-05 1992-08-06 Cis Bio Int Menetelmä teknetium-99m:llä leimatun elinspesifisen aineen valmistamiseksi
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
WO1992018536A2 (fr) * 1991-04-22 1992-10-29 Mallinckrodt Medical, Inc. Procede de detection et de localisation de tissus comprenant des recepteurs de neurokinine 1
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5403573A (en) * 1992-04-23 1995-04-04 The Curators Of The University Of Missouri Radiolabeled protein composition and method for radiation synovectomy
US5508020A (en) 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
CA2141739A1 (fr) * 1993-05-03 1994-11-10 Alfons M. Verbruggen Methode de preparation d'une proteine marquee par un radionucleide metallique
ES2114209T3 (es) * 1993-07-19 1998-05-16 Resolution Pharm Inc Queladores de radionuclidos de tipo hidrazino que tienen una configuracion n3s.
US5858327A (en) * 1993-09-03 1999-01-12 Resolutions Pharmaceuticals, Inc. Hydrazino-type N2 S2 radionuclide chelating compounds
US5574140A (en) * 1993-09-03 1996-11-12 Resolution Pharmaceutical Inc. Hydrazino-type N2 S2 chelators
DE19505960A1 (de) * 1995-02-21 1996-08-22 Deutsches Krebsforsch Konjugat zur individuellen Dosierung von Arzneimitteln
US6043256A (en) * 1996-09-16 2000-03-28 Grassetti; Davide R. Antimutagenic agents
KR100367125B1 (ko) * 1996-12-02 2003-08-27 그라코 인크. 패턴제어식분배장치
EP2380597A1 (fr) 2010-04-20 2011-10-26 Technische Universität München Dérivés de cyclopeptide et ses utilisations
EP2380596A1 (fr) 2010-04-20 2011-10-26 Technische Universität München Dérivés de cyclopentapeptide et ses utilisations
PL3152226T3 (pl) 2014-06-06 2019-10-31 Univ Muenchen Tech Modyfikowane cyklopentapeptydy i ich zastosowania

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3223585A (en) * 1965-02-23 1965-12-14 American Cyanamid Co Pesticidal monosulfur heterocyclic compositions
JPS5835520B2 (ja) * 1976-06-01 1983-08-03 株式会社第一ラジオアイソト−プ研究所 ６−カルボキシメチルチオコルチゾ−ルおよびその誘導体
US4479930A (en) * 1982-07-26 1984-10-30 Trustees Of The University Of Massachusetts Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
US4652519A (en) * 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
ATE66469T1 (de) * 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling

Also Published As

Publication number Publication date
EP0401302B1 (fr) 1995-06-28
FI903917A0 (fi) 1990-08-08
ATE124269T1 (de) 1995-07-15
EP0401302A4 (fr) 1994-03-30
WO1989007456A1 (fr) 1989-08-24
DE68923274D1 (de) 1995-08-03
AU3368689A (en) 1989-09-06
AU635204B2 (en) 1993-03-18
FI903917A7 (fi) 1990-08-08
DE68923274T2 (de) 1995-11-09
IL89222A0 (en) 1989-09-10
AU3105693A (en) 1993-02-25
AU658959B2 (en) 1995-05-04
EP0401302A1 (fr) 1990-12-12

Similar Documents

Publication Publication Date Title
EP0401302B1 (fr) Procede de preparation d'une proteine marquee par un nucleide radio-metallique
US5202451A (en) Anchimeric radiometal chelating compounds
US4897255A (en) Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) Metal radionuclide labeled proteins for diagnosis and therapy
US5162505A (en) Proteins modified with positively charged carriers and compositions prepared therefrom
US5681927A (en) Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
EP0188256B1 (fr) Protéines marquées par un radionuclide d'un métal pour diagnostic et thérapie
KR100235137B1 (ko) 모노아민, 다아민, 티올-함유 금속 킬레이트제
JP2659351B2 (ja) 金属キレート−蛋白質複合体を形成するための多置換ジエチレントリアミンおよびその製造方法
US5037630A (en) Metal radionuclide labeled proteins for diagnosis and therapy
US5242679A (en) Metal radionuclide labeled proteins for diagnosis and therapy
US5095111A (en) Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
EP0510132A1 (fr) Porteurs polymeres servant a la liberation d'agents a liaison covalente.
EP0404605B1 (fr) Tri-aza-macrocycles et leurs procédés de préparation
KR100330794B1 (ko) 혈관질병진단제
EP0420934B1 (fr) Agents d'accouplement bifonctionnels et compositions marquees par radionucleide preparees a partir desdits agents
CA1331450C (fr) Derives de l'acide diethylenetriaminepentaacetique
CA2165537A1 (fr) Proteines marquees par un radionucleide metallique pour des fins de diagnostic et de therapie
WO1994005627A1 (fr) Composes chelateurs bifonctionnels a base d'acide hydroxalique
US5120526A (en) Method of producing metal radionuclide labeled proteins for diagnosis and therapy
US5196515A (en) Thiolactone bifunctional chelating agents for diagnostic and therapeutic products
CA2129033A1 (fr) Composes peptidiques marques par des radio-isotopes
US5395946A (en) Bifunctional chelating agents
US6696551B1 (en) 225Ac-HEHA and related compounds, methods of synthesis and methods of use
WO2000059896A1 (fr) 225ac-heha et composes, procedes de synthese et procedes d'utilisation correspondants

Legal Events

Date Code Title Description
RH Patent void